밀림북 CI (구, 명문의학서적)
 
 
의학서적 회원 로그인
아이디 저장
의학서적 검색
 
의학서적 카테고리 찾기
의학서적 빠른 메뉴 : 더욱 빠르고 편리한 서비스
메뉴얼
USMLE
도서문의게시판
외국도서 수입신청
외국 의학서적 출판사별 / 의학서적 과별도서목록
아마존 의학서적 바로가기
01. 의학서적에 유용한 사이트
02. 의학서적 뉴스링크
03. 환율정보
카드사용내역 확인 : 카드번호와 사용기간을 입력하시면 거래내역을 조회하실 수 있습니다.
의학서적 단체구매안내 : 의학서적 단체구매 및 의학서적 대량구매를 문의하시면 친절하게 해결해드립니다.
의학서적 구입 무통장 입금안내 : 우리은행 > 203-05-024131 / 농협 > 928-12-030605 | 예금주 : 윤진희
국외 의학서적 검색
아마존 의학서적 검색
Barns&Noble 의학서적 검색
Home 과별도서목록의학과분류기초의학
 
 
Plotkin's Vaccines, 8e
 

zoom
 
출판사 Elsevier
저자 Walter Orenstein , Paul A. Offit , Kathryn M. Edwards
출간일 2023/3
페이지 수 1734
Illustrations  
ISBN 9780323790581 / 0323790585
판본 8 판
커버 Hardcover
주문수량
List Price $ 388.99
정가 ₩ 540,000
회원가 ₩ 480,000
※해외주문 도서 안내 :

- 해외 및 국내 입고 사항에 따라 2~8주 이상 소요될 수 있으며. 취소 및 반품이 불가능합니다.
- 해외주문도서는 해외 출판사 사정에 의해 품절/지연될수 있습니다.
※교환 및 반품안내 :

- 교환이나 반품시 상품 수령후 3일이내 교환이나 반품 의사를 알려주시고 일주일이내에 저희쪽으로 상품이 입고되어야합니다.
  시일이 경과되면 반품이 불가합니다.
- 변심에 의한 교환이나 반품시, 배송비는 고객님께서 부담하시며, 오배송이나 상품 불량시에는 무료 교환이 가능합니다.
- 반품시에는 반품상품 검수후 카드 취소를 해드리거나 통장,적립금등으로 환불 조치 해 드립니다.
※배송안내 :

- 제주도및 도서산간지역은 택배비가 추가될수 있습니다.
도서 소개 | 목차 | 서평쓰기
 
 
 
From the latest vaccination evidence, recommendations, and protocols . . . to new vaccine development and the use of vaccines in reducing disease, Plotkin’s Vaccines, 8th Edition, covers every aspect of vaccination. Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin’s Vaccines is a must-have reference for current, authoritative information in this fast-moving field. * Contains all-new chapters on COVID-19, vaccine hesitancy, and non-specific effects of vaccines, as well as significantly revised content on new vaccine technologies such as mRNA vaccines, emerging vaccines, and technologies to improve immunization.

* Presents exciting new data on evolution of adjuvants across the centuries, dengue vaccines, human papillomavirus vaccines, respiratory syncytial virus vaccines, tuberculosis vaccines, and zoster vaccines.

* Provides up-to-date, authoritative information on vaccine production, available preparations, efficacy and safety, and recommendations for vaccine use, with rationales and data on the impact of vaccination programs on morbidity and mortality.

* Provides complete coverage of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.

* Keeps you up to date with information on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.

*
Covers vaccine-preventable diseases, vaccine science, and licensed vaccine products, as well as product technologies and global regulatory and public health issues.

* Analyzes the cost-benefit and cost-effectiveness of different vaccine options.

* Helps you clearly visualize concepts and objective data through an abundance of tables and figures.

* Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
 
 
 
Section 1: General Aspects of Vaccination
1 A short history of vaccination
2 Vaccine immunology
3 Non-specific effects of Vaccines
4 Correlates of protection
5 The vaccine industry
6 Vaccine manufacturing
7 Evolution of adjuvants across the centuries
8 Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
9 Passive immunization
Section 2: Licenced Vaccines and Vaccines in Development
10 General immunization practices
11 Human Adenovirus vaccines
12 Anthrax vaccines
13 EMERGING Diseases and Emerging VACCINES (Military)
14 Cancer vaccines
15 Cholera vaccines
16 Combination vaccines
17 Coronavirus
18 Cytomegalovirus vaccines
19 Dengue vaccines
20 Diarrhea caused by bacteria
21 Diphtheria toxoid
22 Ebola vaccines
23 Enterovirus
24 Epstein-Barr virus vaccines
25 Haemophilus influenzae type b vaccines
26 Hepatitis A vaccines
27 Hepatitis B vaccines
28 Hepatitis C vaccines
29 Hepatitis E vaccines
30 Herpes simplex virus vaccines
31 Human immunodeficiency virus vaccines
32 Human papillomavirus vaccines
33 Inactivated influenza vaccines
34 Influenza vaccine—live
35 Japanese encephalitis vaccines
36 Lyme disease vaccines
37 Malaria vaccines
38 Measles vaccine
39 Meningococcal Capsular A, B, C, W, and Y Conjugate Vaccines
40 Meningococcal Capsular B Vaccines
41 Mumps vaccines
42 Noninfectious disease vaccines
43 Norovirus
44 Norovirus
44 Parasitic disease vaccines
45 Pertussis vaccines
46 Plague vaccines
47 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines
48 Pneumococcal polysaccharide vaccines
49 Poliovirus vaccine—inactivated
50 Poliovirus vaccine—live
51 Rabies vaccines
52 Respiratory syncytial virus vaccines
53 Rotavirus vaccines
54 Rubella vaccine
55 Smallpox and vaccinia
56 Staphylococcus aureus vaccines
57 Streptococcus group A vaccines
58 Streptococcus group B vaccines
59 Tetanus toxoid
60 Tick-borne encephalitis virus vaccines
61 Tuberculosis vaccines
62 Typhoid fever vaccines
63 Varicella vaccine
64 Yellow fever vaccine
65 Zika vaccine
66 Zoster vaccine
67 Technologies for making new vaccines
68 Section 3: New Technologies
68 The development of gene-based vectors for immunization
69 Technologies to Improve Immunization
70 Vaccination of immunocompromised hosts
71 Section 4: Vaccination in Special Groups
71 Vaccines for international travel
72 Vaccines for health care personnel
73 Vaccination of pregnant women
74 Vaccination of pregnant women
74 Immunization in the United States
75 Immunization in Europe
76 Section 5: Public Health and Regulatory Issues
76 Immunization in the Asia-Pacific region
77 Immunization in developing countries
78 Community Protection
79 Economic analyses of vaccine policies
80 Regulation and testing of vaccines IN THE US
81 Regulation of vaccines in Europe
82 Regulation of vaccines in low and middle-income countries
83 Vaccine safety
84 Vaccine hesitancy
85 Legal issues
86 Ethics
Appendix
Foreword
 
 
 
서평 | 등록일 | 작성자
등록된 서평이 없습니다.
 
1
 
 
작성자 암호
 
도서 소개 | 목차 | 서평쓰기
 
Why? 밀림북 서적은 왜 저렴한가요?
의학서적 출간예정도서 출간예정도서 더보기
의학서적 출간예정도서
의학서적 파격할인도서 30~70% SALE
한눈에 알 수 있는 재생통증치료 - 개원의를 위한 (spiral bound) 구매하기
소규모 건물 짓기 실전공식: 건축주가 알아야 할 부실공사 방지책
내가 만난 길고양이들 1